Stade Brenda, Ali Alaa, Bennett Dainel, Campbell Douglas, Johnston Mary, Lens Cynthia, Tran Sofia, Koren Gideon
Department of Paediatrics, St Michael's Hospital, Toronto, Canada.
Can J Clin Pharmacol. 2009 Winter;16(1):e91-102. Epub 2009 Jan 23.
In Canada the incidence of Fetal Alcohol Spectrum Disorder (FASD) is estimated to be 1 in 100 live births. FASD is the leading cause of developmental and cognitive disabilities in Canada. Only one study has examined the cost of FASD in Canada. In that study we did not include prospective data for infants under the age of one year, costs for adults beyond 21 years or costs for individuals living in institutions.
To calculate a revised estimate of direct and indirect costs associated with FASD at the patient level.
Cross-sectional study design was used. Two-hundred and fifty (250) participants completed the study tool. Participants included caregivers of children, youth and adults, with FASD, from day of birth to 53 years, living in urban and rural communities throughout Canada participated. Participants completed the Health Services Utilization Inventory (HSUI). Key cost components were elicited: direct costs: medical, education, social services, out-of-pocket costs; and indirect costs: productivity losses. Total average costs per individual with FASD were calculated by summing the costs for each in each cost component, and dividing by the sample size. Costs were extrapolated to one year. A stepwise multiple regression analysis was used to identify significant determinants of costs and to calculate the adjusted annual costs associated with FASD.
Total adjusted annual costs associated with FASD at the individual level was $21,642 (95% CI, $19,842; $24,041), compared to $14,342 (95% CI, $12,986; $15,698) in the first study. Severity of the individual's condition, age, and relationship of the individual to the caregiver (biological, adoptive, foster) were significant determinants of costs (p < 0.001). Cost of FASD annually to Canada of those from day of birth to 53 years old, was $5.3 billion (95% CI, $4.12 billion; $6.4 billion).
Study results demonstrated the cost burden of FASD in Canada was profound. Inclusion of infants aged 0 to 1 years, adults beyond the age of 21 years and costs associated with residing in institutions provided a more accurate estimate of the costs of FASD. Implications for practice, policy, and research are discussed. Key words: Alcohol, pregnancy, cost, economic burden, fetal alcohol spectrum disorder.
在加拿大,胎儿酒精谱系障碍(FASD)的发病率估计为每100例活产中有1例。FASD是加拿大发育和认知障碍的主要原因。仅有一项研究调查了加拿大FASD的成本。在该研究中,我们未纳入1岁以下婴儿的前瞻性数据、21岁以上成年人的成本或机构居住者的成本。
计算患者层面与FASD相关的直接和间接成本的修订估计值。
采用横断面研究设计。250名参与者完成了研究工具。参与者包括患有FASD的儿童、青少年和成年人的照料者,年龄从出生到53岁,居住在加拿大城乡社区。参与者完成了卫生服务利用清单(HSUI)。确定了关键成本组成部分:直接成本:医疗、教育、社会服务、自付费用;间接成本:生产力损失。通过将每个成本组成部分的成本相加并除以样本量,计算出每名FASD患者的总平均成本。成本外推至一年。采用逐步多元回归分析确定成本的显著决定因素,并计算与FASD相关的调整后年度成本。
个体层面与FASD相关的调整后年度总成本为21,642美元(95%CI,19,842美元;24,041美元),而第一项研究中的成本为14,342美元(95%CI,12,986美元;15,698美元)。个体病情的严重程度、年龄以及个体与照料者的关系(亲生、收养、寄养)是成本的显著决定因素(p<0.001)。从出生到53岁的加拿大人每年因FASD产生的成本为53亿美元(95%CI,41.2亿美元;64亿美元)。
研究结果表明加拿大FASD的成本负担沉重。纳入0至1岁婴儿、21岁以上成年人以及与机构居住相关的成本,能更准确地估计FASD的成本。讨论了对实践、政策和研究的启示。关键词:酒精、妊娠、成本、经济负担、胎儿酒精谱系障碍。